Cuorips Inc. (TYO:4894)

Japan flag Japan · Delayed Price · Currency is JPY
7,200.00
-100.00 (-1.37%)
At close: Mar 6, 2026
Market Cap59.42B +61.6%
Revenue (ttm)356.00M +947.1%
Net Income-765.00M
EPS-93.78
Shares Out8.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,326,100
Average Volume680,890
Open7,280.00
Previous Close7,300.00
Day's Range6,880.00 - 7,980.00
52-Week Range5,240.00 - 12,400.00
Beta0.87
RSI43.46
Earnings DateFeb 13, 2026

About Cuorips

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 56
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4894
Full Company Profile

Financial Performance

Financial Statements